Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Mandraffino

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Biomedicines|July 27, 2022
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid UnitsRoberto Scicali, Giuseppe Mandraffino, Michele Scuruchi, et al.
Metabolites|May 24, 2024
Ketoacidosis and SGLT2 Inhibitors: A Narrative ReviewCarmela Morace, Giuseppe Lorello, Federica Bellone, et al.
Journal of Personalized Medicine|June 28, 2023
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?Federica Bellone, Carmela Morace, Giulia Impalà, et al.
Italian Journal of Pediatrics|August 31, 2023
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patientsCarmela Morace, Selenia Lorenza Curatola, Giuseppe Mandraffino, et al.
Journal of the American Medical Directors Association|April 30, 2023
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link?Giorgio Basile, Maria C Quattropani, Alberto Sardella, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 6, 2026
Effect of add-on PCSK9 inhibitors on endocan and arterial stiffness in heterozygous familial hypercholesterolemia: a two-lipid center real-world studyArianna Toscano, Giosiana Bosco, Francesco Di Giacomo Barbagallo, et al.
Stem Cells International|February 4, 2016
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseCaterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, et al.
Mechanisms of Ageing and Development|March 22, 2017
CD34+ cell count predicts long lasting life in the oldest oldGiuseppe Mandraffino, Caterina Oriana Aragona, Giorgio Basile, et al.
Children (Basel, Switzerland)|May 27, 2023
Hybrid Palliation for Hypoplastic Borderline Left Ventricle: One More Chance to Biventricular RepairLilia Oreto, Giuseppe Mandraffino, Rita Emanuela Calaciura, et al.
Clinical Biochemistry|October 5, 2010
Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell countGiuseppe Mandraffino, Maria A Sardo, Stefania Riggio, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Biomedicines|July 27, 2022
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid UnitsRoberto Scicali, Giuseppe Mandraffino, Michele Scuruchi, et al.
Metabolites|May 24, 2024
Ketoacidosis and SGLT2 Inhibitors: A Narrative ReviewCarmela Morace, Giuseppe Lorello, Federica Bellone, et al.
Journal of Personalized Medicine|June 28, 2023
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?Federica Bellone, Carmela Morace, Giulia Impalà, et al.
Italian Journal of Pediatrics|August 31, 2023
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patientsCarmela Morace, Selenia Lorenza Curatola, Giuseppe Mandraffino, et al.
Journal of the American Medical Directors Association|April 30, 2023
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link?Giorgio Basile, Maria C Quattropani, Alberto Sardella, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 6, 2026
Effect of add-on PCSK9 inhibitors on endocan and arterial stiffness in heterozygous familial hypercholesterolemia: a two-lipid center real-world studyArianna Toscano, Giosiana Bosco, Francesco Di Giacomo Barbagallo, et al.
Stem Cells International|February 4, 2016
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseCaterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, et al.
Mechanisms of Ageing and Development|March 22, 2017
CD34+ cell count predicts long lasting life in the oldest oldGiuseppe Mandraffino, Caterina Oriana Aragona, Giorgio Basile, et al.
Children (Basel, Switzerland)|May 27, 2023
Hybrid Palliation for Hypoplastic Borderline Left Ventricle: One More Chance to Biventricular RepairLilia Oreto, Giuseppe Mandraffino, Rita Emanuela Calaciura, et al.
Clinical Biochemistry|October 5, 2010
Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell countGiuseppe Mandraffino, Maria A Sardo, Stefania Riggio, et al.
Pageof 8